Proteomics as a research tool in clinical and experimental ophthalmology

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 762-775

  Cryan, Lorna M ^a   O'Brien, Colin ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Age related macular degeneration; Glaucoma; Retinopathy; Tears; Uveal melanoma

Indexed keywords

ALPHA ENOLASE; ANGIOGENIC FACTOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; BETA TUBULIN; BIOLOGICAL MARKER; CALPAIN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CATHEPSIN B; CATHEPSIN D; COCHLIN; COFILIN; CYTOSKELETON PROTEIN; GALECTIN 1; GLUCOCORTICOID; GLYCOPROTEIN GP 100; GROWTH FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; LIPOFUSCIN; METALLOPROTEINASE; MYOCILIN; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMA PROTEIN; RETINOID BINDING PROTEIN; RIBOSOME PROTEIN; VIMENTIN; VITAMIN D BINDING PROTEIN;

BLINDNESS; CELL PROLIFERATION; CLINICAL ASSESSMENT; DIABETIC RETINOPATHY; DRUSEN; ELECTROSPRAY MASS SPECTROMETRY; ENZYME METABOLISM; EYE CANCER; EYE DISEASE; GLAUCOMA; HUMAN; IN VIVO STUDY; INTRAOCULAR PRESSURE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OPHTHALMOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; PSEUDOEXFOLIATION; RETINA BLOOD VESSEL; RETINA DISEASE; RETINA EDEMA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TRABECULECTOMY;

ANIMALIA;

EID: 44649125391     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780094     Document Type: Review

References (91)

1. Warburton, S., Southwick, K., Hardman, R. M., Secrest, A. M. et al., Examining the proteins of functional retinal lipofuscin using proteomic analysis as a guide for understanding its origin. Mol. Vis. 2005, 11, 1122-1134.
2. Ouchi, M., West, K., Crabb, J. W., Kinoshita, S., Kamei, M., Proteomic analysis of vitreous from diabetic macular edema. Exp. Eye Res. 2005, 81, 176-182.
3. Schutt, F., Ueberle, B., Schnolzer, M., Holz, F. G., Kopitz, J., Proteome analysis of lipofuscin in human retinal pigment epithelial cells. FEBS Lett. 2002, 528, 217-221.
4. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I. et al., Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82, 844-851.
5. Frick, K. D., Gower, E. W., Kempen, J. H., Wolff, J. L., Economic impact of visual impairment and blindness in the United States. Arch. Ophthalmol. 2007, 125, 544-550.
6. Vu, H. T., Keeffe, J. E., McCarty, C. A., Taylor, H. R., Impact of unilateral and bilateral vision loss on quality of life. Br. J. Ophthalmol. 2005, 89, 360-363.
7. Quin, G. G., Len, A. C., Billson, F. A., Gillies, M. C., Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 2007, 7, 2636-2650.
8. Garcia-Ramirez, M., Canals, F., Hernandez, C., Colome, N. et al., Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): A new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007, 50, 1294-1303.
9. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J. et al., Extra-cellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13, 181-188.
10. Zamora, D. O., Riviere, M., Choi, D., Pan, Y. et al., Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol. Vis. 2007, 13, 2058-2065.
11. Pike, S. E., Yao, L., Setsuda, J., Jones, K. D. et al., Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999, 94, 2461-2468.
12. Bhattacharya, S. K., Rockwood, E. J., Smith, S. D., Bonilha, V. L. et al., Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J. Biol. Chem. 2005, 280, 6080-6084.
13. Yun, A. J., Murphy, C. G., Polansky, J. R., Newsome, D. A., Alvarado, J. A., Proteins secreted by human trabecular cells. Glucocorticoid and other effects. Invest. Ophthalmol. Vis. Sci. 1989, 30, 2012-2022.
14. Steely, H. T., Dillow, G. W., Bian, L., Grundstad, J. et al., Protein expression in a transformed trabecular meshwork cell line: proteome analysis. Mol. Vis. 2006, 12, 372-383.
15. Zhao, X., Ramsey, K. E., Stephan, D. A., Russell, P., Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest. Ophthalmol. Vis. Sci. 2004, 45, 4023-4034.
16. Picht, G., Welge-Luessen, U., Grehn, F., Lutjen-Drecoll, E., Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239, 199-207.
17. Nakajima, E., David, L. L., Bystrom, C., Shearer, T. R., Azuma, M., Calpain-specific proteolysis in primate retina: Contribution of calpains in cell death. Invest. Ophthalmol. Vis. Sci. 2006, 47, 5469-5475.
18. Whitlock, N. A., Lindsey, K., Agarwal, N., Crosson, C. E., Ma, J. X., Heat shock protein 27 delays Ca2+-induced cell death in a caspase-dependent and -independent manner in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2005, 46, 1085-1091.
19. Lin, H. J., Lai, C. C., Lee Chao, P. D., Fan, S. S. et al., Aloe-emodin metabolites protected N-methyl-d-aspartate-treated retinal ganglion cells by Cu-Zn superoxide dismutase. J. Ocul. Pharmacol. Ther. 2007, 23, 152-171.
20. Tezel, G., Yang, X., Cai, J., Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46, 3177-3187.
21. Aroca-Aguilar, J. D., Sanchez-Sanchez, F., Ghosh, S., Coca-Prados, M., Escribano, J., Myocilin mutations causing glaucoma inhibit the intracellular endoproteolytic cleavage of myocilin between amino acids Arg226 and Ile227. J. Biol. Chem. 2005, 280, 21043-21051.
22. Li, Y., Aroca-Aguilar, J. D., Ghosh, S., Sanchez-Sanchez, F. et al., Interaction of myocilin with the C-terminal region of hevin. Biochem. Biophys. Res. Commun. 2006, 339, 797-804.
23. Joachim, S. C., Bruns, K., Lackner, K. J., Pfeiffer, N., Grus, F. H., Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr. Eye Res. 2007, 32, 501-509.
24. Grus, F. H., Joachim, S. C., Hoffmann, E. M., Pfeiffer, N., Complex autoantibody repertoires in patients with glaucoma. Mol. Vis. 2004, 10, 132-137.
25. Kremmer, S., Kreuzfelder, E., Klein, R., Bontke, N. et al., Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin. Exp. Immunol. 2001, 125, 211-215.
26. Grus, F. H., Joachim, S. C., Bruns, K., Lackner, K. J. et al., Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest. Ophthalmol. Vis. Sci. 2006, 47, 968-976.
27. Vazquez, J., Fernandez-Shaw, C., Marina, A., Haas, C. et al., Antibodies to human brain spectrin in Alzheimer's disease. J. Neuroimmunol. 1996, 68, 39-44.
28. Rohde, E., Tomlinson, A. J., Johnson, D. H., Naylor, S., Comparison of protein mixtures in aqueous humor by membrane preconcentration - capillary electrophoresis - mass spectrometry. Electrophoresis 1998, 19, 2361-2370.
29. Kuchle, M., Ho, T. S., Nguyen, N. X., Hannappel, E., Naumann, G. O., Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest. Ophthalmol. Vis. Sci. 1994, 35, 748-752.
30. Schlotzer-Schrehardt, U., Zenkel, M., Kuchle, M., Sakai, L. Y., Naumann, G. O., Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp. Eye Res. 2001, 73, 765-780.
31. Gartaganis, S. P., Georgakopoulos, C. D., Assouti, M., Mela, E. K. et al., Changes in HNK-1 epitope und collagen type IX in the aqueous humour of patients with pseudoexfoliation syndrome. Curr. Eye Res. 2004, 28, 5-10.
32. Joachim, S. C., Wuenschig, D., Pfeiffer, N., Grus, F. H., IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol. Vis. 2007, 13, 1573-1579.
33. Konstas, A. G., Koliakos, G. G., Karabatsas, C. H., Liakos, P. et al., Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp. Eye Res. 2006, 82, 319-322.
34. Reyes, M. R., Cheng, Q., Chuang, P. Y., Lee, D. A., The effect of antiglaucoma drugs on rabbit aqueous humor proteins determined by gel electrophoresis. J. Ocul. Pharmacol. Ther. 1998, 14, 229-237.
35. Suter, M., Reme, C., Grimm, C., Wenzel, A. et al., Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces epoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 2000, 275, 39625-39630.
36. Bressler, N. M., Bressler, S. B., Fine, S. L., Age-related macular degeneration. Surv. Ophthalmol. 1988, 32, 375-413.
37. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003, 110, 979-986.
38. Umeda, S., Suzuki, M. T., Okamoto, H., Ono, F. et al., Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J.2005, 19, 1683-1685.
39. Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K. et al., Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2002, 99, 14682-14687.
40. Gu, X., Meer, S. G., Miyagi, M., Rayborn, M. E. et al., Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 2003, 278, 42027-42035.
41. Nakata, K., Crabb, J. W., Hollyfield, J. G., Crystallin distribution in Bruch's membrane-choroid complex from AMD and age-matched donor eyes. Exp. Eye Res. 2005, 80, 821-826.
42. Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K. et al., Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005, 115, 422-430.
43. Feeney-Burns, L., Hilderbrand, E. S., Eldridge, S., Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest. Ophthalmol. Vis. Sci. 1984, 25, 195-200.
44. Holz, F. G., Bellmann, C., Margaritidis, M., Schutt, F. et al., Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 1999, 237, 145-152.
45. Godley, B. F., Shamsi, F. A., Liang, F. Q., Jarrett, S. G. et al., Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 2005, 280, 21061-21066.
46. Warburton, S., Davis, W. E., Southwick, K., Xin, H. et al., Proteomic and phototoxic characterization of melanolipofuscin: Correlation to disease and model for its origin. Mol. Vis. 2007, 13, 318-329.
47. Nordgaard, C. L., Berg, K. M., Kapphahn, R. J., Reilly, C. et al., Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47, 815-822.
48. An, E., Lu, X., Flippin, J., Devaney, J. M. et al., Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J. Proteome Res. 2006, 5, 2599-2610.
49. Azarian, S. M., McLeod, I., Lillo, C., Gibbs, D. et al., Proteomic analysis of mature melanosomes from the retinal pigmented epithelium. J. Proteome Res. 2006, 5, 521-529.
50. Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., Ferrington, D. A., The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47, 2280-2290.
51. Joachim, S. C., Bruns, K., Lackner, K. J., Pfeiffer, N., Grus, F. H., Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245, 619-626.
52. de Souza, G. A., Godoy, L. M., Mann, M., Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7, R72.
53. Tsai, P. S., Evans, J. E., Green, K. M., Sullivan, R. M. et al., Proteomic analysis of human meibomian gland secretions. Br. J. Ophthalmol. 2006, 90, 372-377.
54. Li, N., Wang, N., Zheng, J., Liu, X. M. et al., Characterization of human tear proteome using multiple proteamic analysis techniques. J. Proteome Res. 2005, 4, 2052-2061.
55. Fullard, R. J., Tucker, D. L., Changes in human tear protein levels with progressively increasing stimulus. Invest. Ophthalmol. Vis. Sci. 1991, 32, 2290-2301.
56. Salas-Auvert, R., Colmenarez, J., de Ledo, H., Colina, M. et al., Determination of anions in human and animal tear fluid and blood serum by ion chromatography. J. Chromatogr. A 1995, 706, 183-189.
57. Mrugacz, M., Kaczmarski, M., Bakunowicz-Lazarczyk, A., Zelazowska, B. et al., IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis. J. Interferon Cytokine Res. 2006, 26, 71-75.
58. Grus, F. H., Sabuncuo, P., Dick, H. B., Augustin, A. J., Pfeiffer, N., Changes in the tear proteins of diabetic patients. BMC Ophthalmol. 2002, 2, 4.
59. Gachon, A. M., Lacazette, E., Tear lipocalin and the eye's front line of defence. Br. J. Ophthalmol. 1998, 82, 453-455.
60. Fung, K. Y., Morris, C., Sathe, S., Sack, R., Duncan, M. W., Characterization of the in vivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Proteomics 2004, 4, 3953-3959.
61. Sakata, M., Sack, R. A., Sathe, S., Holden, B., Beaton, A. R., Polymorphonuclear leukocyte cells and elastase in tears. Curr. Eye Res. 1997, 16, 810-819.
62. Janssen, P. T., van Bijsterveld, O. P., Origin and biosynthesis of human tear fluid proteins. Invest. Ophthalmol. Vis. Sci. 1983, 24, 623-630.
63. Pflugfelder, S. C., Liu, Z., Monroy, D., Li, D. Q. et al., Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest. Ophthalmol. Vis. Sci. 2000, 41, 1316-1326.
64. Shoji, J., Inada, N., Sawa, M., Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn. J. Ophthalmol. 2006, 50, 195-204.
65. Leonardi, A., Curnow, S. J., Zhan, H., Calder, V. L., Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin. Exp. Allergy 2006, 36, 777-784.
66. Zhou, L., Huang, L. Q., Beuerman, R. W., Grigg, M. E. et al., Proteomic analysis of human tears: Defensin expression after ocular surface surgery. J. Proteome Res. 2004, 3, 410-416.
67. Tomosugi, N., Kitagawa, K., Takahashi, N., Sugai, S., Ishikawa, I., Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J. Proteome Res. 2005, 4, 820-825.
68. Sack, R. A., Conradi, L., Krumholz, D., Beaton, A. et al., Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest. Ophthalmol. Vis. Sci. 2005, 46, 1228-1238.
69. Malvitte, L., Montange, T., Vejux, A., Baudouin, C. et al., Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br. J. Ophthalmol. 2007, 91, 29-32.
70. Moss, S. E., Klein, R., Klein, B. E., Prevalence of and risk factors for dry eye syndrome.Arch. Ophthalmol. 2000, 118, 1264-1268.
71. Mackie, I. A., Seal, D. V., Diagnostic implications of tear protein profiles. Br. J. Ophthalmol. 1984, 68, 321-324.
72. Sack, R. A., Tan, K. O., Tan, A., Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 1992, 33, 626-640.
73. Ham, B. M., Jacob, J. T., Cole, R. B., Single eye analysis and contralateral eye comparison of tear proteins in normal and dry eye model rabbits by MALDI-ToF mass spectrometry using wax-coated target plates. Anal. Bioanal. Chem. 2007, 387, 889-900.
74. Zhao, H., Jumblatt, J. E., Wood, T. O., Jumblatt, M. M., Quantification of MUC5AC protein in human tears. Cornea 2001, 20, 873-877.
75. Funding, M., Vorum, H., Honore, B., Nexo, E., Ehlers, N., Proteomic analysis of aqueous humour from patients with acute corneal rejection. Acta Ophthalmol. Scand. 2005, 83, 31-39.
76. Virgili, G., Gatta, G., Ciccolallo, L., Capocaccia, R. et al., Incidence of uveal melanoma in Europe. Ophthalmology 2007, 114, 2309-2315.
77. Mudhar, H. S., Parsons, M. A., Sisley, K., Rundle, P. et al., A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology 2004, 45, 1-12.
78. Gragoudas, E. S., Egan, K. M., Seddon, J. M., Glynn, R. J. et al., Survival of patients with metastases from uveal melanoma. Ophthalmology 1991, 98, 383-389.
79. Kath, R., Hayungs, J., Bornfeld, N., Sauerwein, W. et al., Prognosis and treatment of disseminated uveal melanoma. Cancer 1993, 72, 2219-2223.
80. Zuidervaart, W., Hensbergen, P. J., Wong, M. C., Deelder, A. M. et al., Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest. Ophthalmol. Vis. Sci. 2006, 47, 786-793.
81. Pardo, M., Garcia, A., Antrobus, R., Blanco, M. J. et al., Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum. J. Proteome Res. 2007, 6, 2802-2811.
82. Missotten, G. S., Beijnen, J. H., Keunen, J. E., Bonfrer, J. M., Proteomics in uveal melanoma. Melanoma Res. 2003, 13, 627-629.
83. Golovleva, I., Bhattacharya, S., Wu, Z., Shaw, N. et al., Disease-causing mutations in the cellular retinaldehyde binding protein tighten and abolish ligand interactions. J. Biol. Chem. 2003, 278, 12397-12402.
84. Nawrot, M., West, K., Huang, J., Possin, D. E. et al., Cellular retinaldehyde-binding protein interacts with ERM-binding phosphoprotein 50 in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2004, 45, 393-401.
85. Khanna, H., Hurd, T. W., Lillo, C., Shu, X. et al., RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins. J. Biol. Chem. 2005, 280, 33580-33587.
86. Shu, X., Fry, A. M., Tulloch, B., Manson, F. D. et al., RPGR ORF15 isoform co-localizes with RPGRIP1 at centrioles and basal bodies and interacts with nucleophosmin. Hum. Mol. Genet. 2005, 14, 1183-1197.
87. Xi, Q., Pauer, G. J., Marmorstein, A. D., Crabb, J. W., Hagstrom, S. A., Tubby-like protein 1 (TULP1) interacts with F-actin in photoreceptor cells. Invest. Ophthalmol. Vis. Sci. 2005, 46, 4754-4761.
88. Cornett, D. S., Reyzer, M. L., Chaurand, P., Caprioli, R. M., MALDI imaging mass spectrometry: Molecular snapshots of biochemical systems. Nat. Methods 2007, 4, 828-833.
89. Cooks, R. G., Ouyang, Z., Takats, Z., Wiseman, J. M., Detection technologies, ambient mass spectrometry. Science 2006, 311, 1566-1570.
90. Bowes Rickman, C., Ebright, J. N., Zavodni, Z. J., Yu, L. et al., Defining the human macula transcriptome and candidate retinal disease genes using EyeSAGE. Invest. Ophthalmol. Vis. Sci. 2006, 47, 2305-2316.
91. Assouti, M., Vynios, D. H., Anagnostides, S. T., Papadopoulos, G. et al., Collagen type IX and HNK-1 epitope in tears of patients with pseudoexfoliation syndrome. Biochim. Biophys. Acta 2006, 1762, 54-58.